TwelveStone provides Tezspire® Injection Treatment for patients age 12 and older with severe asthma or inadequately controlled chronic rhinosinusitis with nasal polyps. 

This add-on maintenance therapy focuses on long-term respiratory control and preventing flare-ups rather than providing acute relief.

Our clinical team manages the entire prior authorization process and coordinates with your insurance provider to verify coverage. We work directly with your specialist to streamline intake and schedule your treatment at any of our 30+ infusion center locations across the Southeast.

Determining if Tezspire is the Right Fit for Your Respiratory Health

Daily inhalers and standard controller therapies sometimes fail to prevent frequent flare-ups or persistent shortness of breath. When symptoms remain uncontrolled despite consistent medication use, specialists often recommend a biologic as an add-on maintenance treatment. This approach targets underlying inflammation that traditional controllers might miss.

Tezspire® Injection Treatment is FDA-labeled for the add-on maintenance of severe asthma in adults and pediatric patients aged 12 and older. It is also indicated for inadequately controlled chronic rhinosinusitis with nasal polyps (CRSwNP) in these same groups. This medication works across various asthma subtypes regardless of a specific phenotype.

This biologic is a long-term maintenance therapy and not a rescue treatment. It cannot treat acute bronchospasm or status asthmaticus, and it does not replace a fast-acting rescue inhaler for sudden emergencies. Contact TwelveStone to coordinate next steps for asthma care and the management of other chronic conditions.

Understanding the Mechanism and Dosing of Tezspire® Injection Treatment

This medication works by blocking thymic stromal lymphopoietin (TSLP), an upstream inflammatory signal in the lungs. Unlike other biologics that target specific downstream triggers, this therapy intervenes earlier in the inflammatory chain. This approach prevents the initial immune response that leads to airway inflammation and severe asthma symptoms.

The standard Tezspire injection schedule includes:

  • A 210 mg subcutaneous injection
  • One administration every four weeks
  • Consistent clinical monitoring for effectiveness

Most patients notice initial breathing improvements within the first few weeks. However, physicians typically evaluate the full clinical benefit over 4 to 12 weeks of consistent therapy. Your prescribing specialist will continue to track your lung function and flare-up frequency throughout this period to determine the long-term impact on your quality of life.

TwelveStone clinical teams focus on administration support and care coordination for Tezspire® Injection Treatment. We ensure the medication is delivered according to your specific medical strategy without altering the original prescribing plan. This structured approach provides the data your specialist needs to manage your respiratory health.

Professional Administration and Home Care Logistics

Tezspire® Injection Treatment follows a 28-day schedule to maintain consistent control of respiratory symptoms. Patients may choose administration from our clinical staff at a TwelveStone infusion center or, after clinical training, use a prefilled pen at home.

  1. Arrival and medication order verification
  2. Subcutaneous injection by a licensed nurse
  3. Brief monitoring period
  4. Next appointment scheduling

Visits to our centers are designed for efficiency and emphasize patient comfort during every step of the process.

Injection Sites and Home Care

Nurses administer doses into the thigh, abdomen, or back of the upper arm. We rotate these locations monthly to prevent skin irritation and ensure the medication absorbs correctly. This rotation helps maintain tissue health and prevents scarring during long-term therapy.

Keep home-use prefilled pens refrigerated between 36°F and 46°F. Use a cool, insulated container for travel or during power outages to maintain medication stability. If medication stays at room temperature for more than 30 days, contact our specialty pharmacy for clinical guidance rather than improvising. These structured steps keep your respiratory care on schedule.

Insurance and Financial Support for Tezspire® Injection Treatment

Tezspire is a high-cost biologic medication, and most patients rely on a combination of insurance coverage and manufacturer assistance programs. Your out-of-pocket responsibility varies based on your specific plan design and the administration setting. There are generally two pathways for accessing this therapy. In a clinic setting, providers often use a buy-and-bill process where the facility procures the drug and bills your medical insurance. Other plans require specialty pharmacy distribution where the medication is shipped directly to the site of care.

TwelveStone serves as an administrative bridge between your physician and the insurance carrier. Our team handles the complex administrative requirements necessary to start treatment.

  • Benefits verification and investigation
  • Prior authorization submission and tracking
  • Clinical documentation and insurance appeals
  • Enrollment in manufacturer copay support programs

We provide these services to ensure you understand your financial responsibility before your first appointment. Request a benefits verification to confirm your coverage and start your treatment process.

Frequently Asked Questions About Tezspire® Treatment

Patients often have practical questions regarding the logistics and safety of starting a biologic therapy. Preparing for your first appointment involves coordinating with your clinical team to ensure all administrative steps are complete.

Before your first injection, our team confirms the following details:

  • Active prior authorization from your insurance provider
  • Verification of the medication shipment to our center
  • Current list of all rescue and maintenance inhalers
  • Confirmation of your most recent specialist consultation

This thorough intake process prevents treatment delays and ensures that your therapy begins under the safest possible clinical conditions.

Tezspire is a maintenance medication and is not intended to treat sudden, acute asthma symptoms or a flare-up in progress. It works over time to reduce the underlying inflammation that leads to attacks, but it does not provide the immediate airway opening required during a respiratory emergency. You must continue to carry a fast-acting rescue inhaler as prescribed by your physician for use during sudden shortness of breath.

The standard dosing schedule for this medication is one subcutaneous injection every four weeks, or approximately every 28 days. Maintaining this regular interval is necessary to keep the medication at a consistent level in your system for optimal symptom control. If you miss a scheduled appointment, contact your healthcare provider immediately to reschedule. You should not receive a double dose or take an extra injection to compensate for a missed visit unless specifically directed by your prescriber.

Common side effects associated with this treatment include a sore throat, joint pain, or mild irritation at the site of the injection. While most reactions are manageable, you should monitor for signs of hypersensitivity, such as a severe rash, swelling of the face, or worsening breathing difficulties. Our clinical staff provides monitoring during and immediately after your administration to ensure any immediate adverse reactions are addressed. Contact your physician if you experience persistent joint discomfort or new respiratory symptoms between visits.

You should avoid receiving live or live-attenuated vaccines while undergoing treatment with this biologic. Non-live vaccines, such as the standard flu shot or certain pneumonia vaccines, are generally permissible, but you must coordinate the timing with your prescribing specialist. Discussing your vaccination history and future needs with your healthcare team helps prevent potential interactions and ensures your immune system responds effectively to the immunizations.

Each biologic medication targets a different part of the immune system’s inflammatory response, and the right choice depends on your specific asthma phenotype and comorbidities. While some treatments focus on specific cells like eosinophils, Tezspire blocks an upstream protein called TSLP, which may make it effective for a broader range of asthma types. Your specialist will use blood tests and your medical history to determine which clinical mechanism is most appropriate for your condition.

You “?’’ not stop or change the dosage of your current asthma medications, including oral or inhaled steroids, when you begin biologic therapy. These treatments are meant to work together to improve your overall lung function and reduce the frequency of flare-ups. Any reduction in your other medications must be a gradual process managed exclusively by your prescribing physician after they have observed a sustained positive response to the new treatment.

Start your Tezspire® treatment today. Request your benefits verification or schedule a consultation with TwelveStone Health Partners.